119 related articles for article (PubMed ID: 23603097)
1. The NFL-TBS.40-63 anti-glioblastoma peptide enters selectively in glioma cells by endocytosis.
Lépinoux-Chambaud C; Eyer J
Int J Pharm; 2013 Oct; 454(2):738-47. PubMed ID: 23603097
[TBL] [Abstract][Full Text] [Related]
2. The effect of functionalizing lipid nanocapsules with NFL-TBS.40-63 peptide on their uptake by glioblastoma cells.
Balzeau J; Pinier M; Berges R; Saulnier P; Benoit JP; Eyer J
Biomaterials; 2013 Apr; 34(13):3381-9. PubMed ID: 23391494
[TBL] [Abstract][Full Text] [Related]
3. Neurofilaments and NFL-TBS.40-63 peptide penetrate oligodendrocytes through clathrin-dependent endocytosis to promote their growth and survival in vitro.
Fressinaud C; Eyer J
Neuroscience; 2015 Jul; 298():42-51. PubMed ID: 25862585
[TBL] [Abstract][Full Text] [Related]
4. The vimentin-tubulin binding site peptide (Vim-TBS.58-81) crosses the plasma membrane and enters the nuclei of human glioma cells.
Balzeau J; Peterson A; Eyer J
Int J Pharm; 2012 Feb; 423(1):77-83. PubMed ID: 21575694
[TBL] [Abstract][Full Text] [Related]
5. The NFL-TBS.40-63 anti-glioblastoma peptide disrupts microtubule and mitochondrial networks in the T98G glioma cell line.
Rivalin R; Lepinoux-Chambaud C; Eyer J; Savagner F
PLoS One; 2014; 9(6):e98473. PubMed ID: 24896268
[TBL] [Abstract][Full Text] [Related]
6. Neurofilament-tubulin binding site peptide NFL-TBS.40-63 increases the differentiation of oligodendrocytes in vitro and partially prevents them from lysophosphatidyl choline toxiciy.
Fressinaud C; Eyer J
J Neurosci Res; 2014 Feb; 92(2):243-53. PubMed ID: 24327347
[TBL] [Abstract][Full Text] [Related]
7. The Neurofilament-Derived Peptide NFL-TBS.40-63 Targets Neural Stem Cells and Affects Their Properties.
Lépinoux-Chambaud C; Barreau K; Eyer J
Stem Cells Transl Med; 2016 Jul; 5(7):901-13. PubMed ID: 27177578
[TBL] [Abstract][Full Text] [Related]
8. Structure-function analysis of the glioma targeting NFL-TBS.40-63 peptide corresponding to the tubulin-binding site on the light neurofilament subunit.
Berges R; Balzeau J; Takahashi M; Prevost C; Eyer J
PLoS One; 2012; 7(11):e49436. PubMed ID: 23152907
[TBL] [Abstract][Full Text] [Related]
9. Investigating the Structural Variability and Binding Modes of the Glioma Targeting NFL-TBS.40-63 Peptide on Tubulin.
Laurin Y; Savarin P; Robert CH; Takahashi M; Eyer J; Prevost C; Sacquin-Mora S
Biochemistry; 2015 Jun; 54(23):3660-9. PubMed ID: 26016807
[TBL] [Abstract][Full Text] [Related]
10. Effect of the NFL-TBS.40-63 peptide on canine glioblastoma cells.
Audrey G; Claire LC; Joel E
Int J Pharm; 2021 Aug; 605():120811. PubMed ID: 34144141
[TBL] [Abstract][Full Text] [Related]
11. The NFL-TBS.40-63 peptide targets and kills glioblastoma stem cells derived from human patients and also targets nanocapsules into these cells.
Lépinoux-Chambaud C; Eyer J
Int J Pharm; 2019 Jul; 566():218-228. PubMed ID: 31132447
[TBL] [Abstract][Full Text] [Related]
12. Cationic cell-penetrating peptides interfere with TNF signalling by induction of TNF receptor internalization.
Fotin-Mleczek M; Welte S; Mader O; Duchardt F; Fischer R; Hufnagel H; Scheurich P; Brock R
J Cell Sci; 2005 Aug; 118(Pt 15):3339-51. PubMed ID: 16079278
[TBL] [Abstract][Full Text] [Related]
13. Tat(48-60) peptide amino acid sequence is not unique in its cell penetrating properties and cell-surface glycosaminoglycans inhibit its cellular uptake.
Subrizi A; Tuominen E; Bunker A; Róg T; Antopolsky M; Urtti A
J Control Release; 2012 Mar; 158(2):277-85. PubMed ID: 22100438
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of cell-penetrating peptide-mediated peptide delivery.
Jones SW; Christison R; Bundell K; Voyce CJ; Brockbank SM; Newham P; Lindsay MA
Br J Pharmacol; 2005 Aug; 145(8):1093-102. PubMed ID: 15937518
[TBL] [Abstract][Full Text] [Related]
15. Investigation on the self-assembly of the NFL-TBS.40-63 peptide and its interaction with gold nanoparticles as a delivery agent for glioblastoma.
Alnemeh-Al Ali H; Griveau A; Artzner F; Dupont A; Lautram N; Jourdain MA; Eyer J
Int J Pharm X; 2022 Dec; 4():100128. PubMed ID: 36204592
[TBL] [Abstract][Full Text] [Related]
16. Lipid Nanoparticles Vectorized with NFL-TBS.40-63 Peptide Target Oligodendrocytes and Promote Neurotrophin-3 Effects After Demyelination In Vitro.
Fressinaud C; Thomas O; Umerska AM; Saulnier P
Neurochem Res; 2020 Nov; 45(11):2732-2748. PubMed ID: 32910302
[TBL] [Abstract][Full Text] [Related]
17. The neurofilament derived-peptide NFL-TBS.40-63 enters in-vitro in human neural stem cells and increases their differentiation.
Barreau K; Montero-Menei C; Eyer J
PLoS One; 2018; 13(8):e0201578. PubMed ID: 30092042
[TBL] [Abstract][Full Text] [Related]
18. Biological activity of gold nanoparticles combined with the NFL-TBS.40-63 peptide, or with other cell penetrating peptides, on rat glioblastoma cells.
Griveau A; Arib C; Spadavecchia J; Eyer J
Int J Pharm X; 2022 Dec; 4():100129. PubMed ID: 36164551
[TBL] [Abstract][Full Text] [Related]
19. Entry of a cationic lytic-type peptide into the cytoplasm via endocytosis-dependent and -independent pathways in human glioma U251 cells.
Ohara K; Kohno M; Hamada T; Kawakami K
Peptides; 2013 Dec; 50():28-35. PubMed ID: 24095870
[TBL] [Abstract][Full Text] [Related]
20. Translocation of cell-penetrating peptides across the plasma membrane is controlled by cholesterol and microenvironment created by membranous proteins.
Pae J; Säälik P; Liivamägi L; Lubenets D; Arukuusk P; Langel Ü; Pooga M
J Control Release; 2014 Oct; 192():103-13. PubMed ID: 25016968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
